Cyberknife treatment for low and intermediate risk prostate cancer.
Detti B, Bonomo P, Masi L, Doro R, Cipressi S, Iermano C, Bonucci I, Franceschini D, Di Cataldo V, Di Brina L, Baki M, Simontacchi G, Meattini I, Carini M, Serni S, Nicita G, Livi L.
Detti B, et al. Among authors: cipressi s.
Cancer Invest. 2015 May;33(5):188-92. doi: 10.3109/07357907.2015.1019679. Epub 2015 Apr 1.
Cancer Invest. 2015.
PMID: 25831274